Tag Archives | T Hafner

The Use of Pharmaceutical Information for Decision Making in Namibia’s National ART Program: Assessment Report

SIAPS conducted this assessment to determine the extent to which pharmaceutical information generated from the Electronic Dispensing Tool (EDT) and dashboard is used by key stakeholders in the national antiretroviral therapy (ART) program in making decisions regarding the management of medicines and related services and, to the extent possible, identify potential influences on program outcomes. The assessment used a descriptive case study approach based on 28 interviews conducted with key stakeholders in the national ART program and a desk review of program-related documents and publications.

Read full story · Comments are closed

Strengthening Governance in Pharmaceutical Systems: A Compendium of Country Case Studies

SIAPS and its predecessor programs have assisted numerous countries in strengthening governance to promote robust decision making, enhance accountability, reduce opportunities for corruption, and improve efficiencies to enable better access to and use of quality-assured medicines. This compendium draws on these experiences and provides a collection of examples of strategies and approaches for strengthening governance in pharmaceutical systems. The compendium highlights accumulated insights into factors that may have enabled or constrained the success of governance improvement initiatives. The intention is to systematically bolster knowledge, in alignment with USAID’s collaborating, learning, and adapting approach, so that stakeholders may examine the applicability of lessons learned and apply them in different settings to maximize resources and attain better development results. The compendium begins by defining governance, then explains its importance in pharmaceutical systems and introduces the framework SIAPS has used to guide its governance strengthening activities. It presents eight case studies on SIAPS’ work in enhancing governance in pharmaceutical systems, summarizes challenges commonly encountered and lessons learned, and closes with some reflections on the usefulness of SIAPS’ governance-strengthening framework.

Read full story · Comments are closed

Defining pharmaceutical systems strengthening: concepts to enable measurement

Hafner T, Walkowiak H, Lee D, Aboagye-Nyame F. Defining pharmaceutical systems strengthening: Concepts to enable measurement. Health Policy and Planning Advance Access. 2016; 1-13.

Read the full article

 

Read full story · Comments are closed